This session will address the treatment approaches using Fc-fusion proteins in hematologic disorders such as Immune Thrombocytopenic Purpura (ITP), autoimmune hemolytic anemia, and hemophilia. Mechanism of action, goals of therapy, clinical efficacy, appropriate use, and safety of these agents will be discussed.
Michael Tarantino, MD – Medical Director and President, The Bleeding and Clotting Disorder Institue
Nursing 1 contact hour
ACPE 1 contact hour
1 IgCN® / IgCP® Recertification Units